ライフサイエンスコーパス: somatoform

1 d loadings: 0.89 for internalizing, 0.76 for somatoform, 0.70 for disinhibition, 0.62 for thought dis

2 We also found novel somatoform and antagonism dimensions, which this investi

3 Present evidence suggests that somatoform and factitious disorders are over-represented

4 e study of the characteristics of women with somatoform and factitious disorders who involve their ch

5 s is the first study to include a variety of somatoform and personality disorders.

6 nced with additional history for symptoms of somatoform and psychological disorders and alarm symptom

7 Detachment, somatoform, and internalizing had the most behavioral ma

8 disinhibition, antagonism, thought disorder, somatoform, and the p-factor; 27 behavior markers derive

9 ts assigned ozanimod 0.5 mg: optic neuritis, somatoform autonomic dysfunction, and cervical squamous

10 ith less dramatic features, fewer additional somatoform complaints, and lower dissociation scores.

11 correlates more specific to internalizing or somatoform conditions, and others common to both, thereb

12 d disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.

13 nd Statistical Manual of Mental Disorders-IV somatoform diagnoses.

14 line personality disorder (factors 3 and 4), somatoform disorder (factors 1 and 2), paranoid and depe

15 he basis of DSM-IV criteria and absence of a somatoform disorder and a plausible medical explanation.

16 ive, while the criteria for undifferentiated somatoform disorder are overly inclusive.

17 patients, however, no conclusive features of somatoform disorder or psychogenic disorder can be found

18 iodemographic characteristics, patients with somatoform disorder still had more primary care visits (

19 m posttraumatic stress disorder, depression, somatoform disorder, and malingering.

20 asquerading as anaphylaxis, undifferentiated somatoform disorder, panic attacks, globus hystericus, v

21 han the DSM-IV diagnosis of undifferentiated somatoform disorder.

22 t many patients fulfil strict criteria for a somatoform disorder/psychogenic dystonia.

23 conditions (74 patients [32.2%]), suspected somatoform disorders (111 patients [48.3%]), and sexual

24 ommon current psychiatric diagnoses included somatoform disorders (89%), dissociative disorders (91%)

25 CI, 1.07-1.10); anxiety, stress-related, and somatoform disorders (IRR, 1.07; 95% CI, 1.05-1.09); moo

26 stent with advancing research on anxiety and somatoform disorders and offers greater insights into th

27 Somatoform disorders are an important determinant of med

28 Somatoform disorders in pediatric care are associated wi

29 Reported AUROCs for identification of somatoform disorders ranged from 0.63 (95% CI, 0.50-0.76

30 Only 3 cases of somatoform disorders were identified, and all were assoc

31 improve both the reliability and validity of somatoform disorders will be a major challenge.

32 osis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (cluster B and par

33 m disorders, substance abuse, and anxiety or somatoform disorders).

34 mood disorders, neurotic stress-related and somatoform disorders, and a range of developmental and c

35 t nonepileptic seizures are in a spectrum of somatoform disorders, diagnostic literature is reviewed

36 ess disorder, obsessive-compulsive disorder, somatoform disorders, eating disorders, attention-defici

37 ology and maintenance of somatic disease and somatoform disorders, is an important factor in the beha

38 the diagnoses subsumed under the category of somatoform disorders, various nosological questions are

39 nd sensory symptoms, functional seizures and somatoform disorders.

40 nt a structured assessment of depressive and somatoform disorders.

41 h as sleep disorder, depression, anxiety and somatoform disorders.

42 ood disorders; neurotic, stress-related, and somatoform disorders; eating disorders; specific persona

43 her anxiety disorders, eating disorders, and somatoform disorders; higher scores on most subscales of

44 psychotic, posttraumatic stress or anxiety, somatoform, neurocognitive, and eating disorders, as wel

45 nt (R = 0.42; 95% CI, 0.29-0.54) followed by somatoform (R = 0.41; 95% CI, 0.30-0.53), internalizing

46 order (psychosis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (clust

47 traditional diagnoses, the internalizing and somatoform spectra demonstrated substantially improved u

48 alidity and utility of the internalizing and somatoform spectra of HiTOP, which together provide supp

49 th outcomes as measured by the Screening for Somatoform Symptoms Conversion Disorder subscale and Pat

50 ealth Questionnaire-15 and the Screening for Somatoform Symptoms Conversion Disorder subscale.

51 umber of physical symptoms and the number of somatoform symptoms correlated with difficulty (r = 0.39

52 s and physician-assessed psychopathology and somatoform symptoms were evaluated by using the PRIME-MD

53 ve Experiences Scale, and Screening Test for Somatoform Symptoms) a mean of 11.9 years after manifest